Lasa Supergeneri

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE670X01014
NSEID: LASA
BSEID: 540702

INR

9.54

0.43 (4.72%)

BSENSE

Dec 12

BSE+NSE Vol: 1.07 lacs

{
  "main_header": {
    "sid": 1002834,
    "name": "Lasa Supergeneri",
    "stock_name": "Lasa Supergeneri",
    "full_name": "Lasa Supergenerics Ltd",
    "name_url": "stocks-analysis/lasa-supergeneri",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "9.54",
    "chg": 0.43,
    "chgp": "4.72%",
    "dir": 1,
    "prev_price": "9.11",
    "mcapval": "50.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540702,
    "symbol": "LASA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE670X01014",
    "curr_date": "Dec 12",
    "curr_time": "",
    "bse_nse_vol": "1.07 lacs",
    "exc_status": "Active",
    "traded_date": "Dec 12, 2025",
    "traded_date_str": "2025 12 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lasa-supergeneri-1002834-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Lasa Supergeneri falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-lasa-supergeneri-fallingrising-3757829",
        "imagepath": "",
        "date": "2025-12-13 01:17:14",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Context</strong></p>\n<p>Despite the recent positive price action, Lasa Supergenerics has endured a challenging period over the past year and beyond. The stock has declined by 64.01% over the last 12 months and by a staggering 87.85% over five years, significantly underperforming the broader Sensex benchmark, which has gained 4.89% and 84.97% respectively over the same periods. Year-to-date, the stock remains down 62.11%, contrasting sharply with the Sensex’s 9.12% gain. This prolonged underperformance highlights the stock’s vulnerability and the cautious stance investors have maintained.</p>\n<p>However, the recent price increase on 12-Dec marks a departure from this trend. The stock outperformed its sector by 5.67% on the day, suggesting renewed buying intere..."
      },
      {
        "title": "Lasa Supergeneri Sees Revision in Market Evaluation Amid Challenging Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lasa-supergeneri-downgraded-to-strong-sell-amid-weak-fundamentals-and-negative-financial-trends-3750112",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/LasaSupergeneri_mojoScore_3750112.png",
        "date": "2025-12-07 10:10:21",
        "description": "Lasa Supergeneri, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation metrics. This shift reflects recent developments across multiple analytical parameters, highlighting ongoing challenges in the company’s financial and operational performance."
      },
      {
        "title": "Lasa Supergenerics Hits Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-hits-lower-circuit-amid-heavy-selling-pressure-3725750",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LasaSupergeneri_stocks_hitting_lower_circuit_3725750.png",
        "date": "2025-11-24 15:00:09",
        "description": "Lasa Supergenerics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 24 Nov 2025 as it hit its lower circuit limit, reflecting intense selling pressure and a significant daily loss that outpaced both its sector and the broader market indices."
      },
      {
        "title": "Lasa Supergenerics Faces Intense Selling Pressure Amid Prolonged Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-plunges-to-lower-circuit-amid-intense-selling-pressure-3725699",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LasaSupergeneri_only_sellers_3725699.png",
        "date": "2025-11-24 14:21:03",
        "description": "Lasa Supergenerics Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.91% today and exhibiting a complete absence of buyers. This extreme selling activity reflects distress signals as the pharmaceutical company continues to underperform against broader market indices and its sector peers."
      },
      {
        "title": "Why is Lasa Supergeneri falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-lasa-supergeneri-fallingrising-3716464",
        "imagepath": "",
        "date": "2025-11-19 23:35:31",
        "description": "As of 19-Nov, Lasa Supergenerics Ltd is currently priced at 10.27, reflecting a slight increase of 0.02 (0.2%). The stock has experienced a trend reversal, gaining after four consecutive days of decline. However, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally bearish trend. Additionally, there has been a significant drop in investor participation, with delivery volume on 18 Nov falling by 91.48% compared to the 5-day average. The stock has underperformed in the longer term, with a year-to-date decline of 60.26% and a 5-year decline of 86.66%, which suggests ongoing challenges despite today's minor uptick.\n\nIn the broader market context, Lasa Supergenerics' short-term performance has been notably poor compared to the benchmark Sensex, which has gained 0.85% over the past week while Lasa has declined by 6.47%. This stark contrast highlights the stoc..."
      },
      {
        "title": "Lasa Supergenerics Ltd Stock Hits Upper Circuit Limit with Intraday High of Rs 10.76",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-ltd-stock-hits-upper-circuit-limit-with-intraday-high-of-rs-1076-3707147",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LasaSupergeneri_stocks_hitting_upper_circuit_3707147.png",
        "date": "2025-11-17 11:00:18",
        "description": "Lasa Supergenerics Ltd, a microcap in the Pharmaceuticals & Biotechnology sector, reached its upper circuit limit today, with a notable increase in investor participation. The stock's trading volume surged significantly, reflecting strong market activity despite being below its moving averages across various time frames."
      },
      {
        "title": "How has been the historical performance of Lasa Supergeneri?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-lasa-supergeneri-3703767",
        "imagepath": "",
        "date": "2025-11-15 00:12:35",
        "description": "Answer:\nThe historical performance of Lasa Supergeneri shows significant fluctuations in key financial metrics over the years.\n\nBreakdown:\nLasa Supergeneri's net sales have varied, peaking at 202.38 Cr in March 2021 but declining to 142.45 Cr by March 2025, with a notable drop from 137.13 Cr in March 2022. Total operating income followed a similar trend, reflecting the same values as net sales. Raw material costs increased to 108.10 Cr in March 2025 from 79.28 Cr in March 2024, while total expenditure rose to 136.18 Cr in March 2025, indicating rising operational costs. Operating profit, which was positive at 47.22 Cr in March 2021, turned negative in March 2023 at -6.59 Cr and improved to 6.27 Cr by March 2025. Profit before tax remained negative, reaching -19.38 Cr in March 2025, with profit after tax also negative at -14.76 Cr. The company's equity capital remained stable at 50.10 Cr from March 2023 to M..."
      },
      {
        "title": "Why is Lasa Supergeneri falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-lasa-supergeneri-fallingrising-3691327",
        "imagepath": "",
        "date": "2025-11-11 23:23:57",
        "description": "As of 11-Nov, Lasa Supergenerics Ltd is experiencing a decline in its stock price, currently at 10.76, which reflects a decrease of 0.56 or 4.95%. The stock has been underperforming significantly, with a consecutive fall over the last five days resulting in an overall drop of 8.03%. It is trading below all key moving averages, indicating a bearish trend. Additionally, investor participation has decreased sharply, with delivery volume falling by 80.49% compared to the five-day average. The stock has also shown poor performance over various periods, with year-to-date returns down by 58.36% and a staggering 86.07% decline over the past five years.\n\nIn the broader market context, Lasa Supergenerics Ltd's recent performance contrasts sharply with the Sensex, which has gained 7.34% year-to-date. Over the past week, while the Sensex has increased by 0.49%, Lasa Supergenerics has declined by 7.88%, highlighting its..."
      },
      {
        "title": "Lasa Supergenerics Ltd Hits Lower Circuit Limit with Low Price of Rs 11.02",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lasa-supergenerics-ltd-hits-lower-circuit-limit-with-low-price-of-rs-1102-3666072",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/LasaSupergeneri_stocks_hitting_lower_circuit_3666072.png",
        "date": "2025-11-03 11:00:18",
        "description": "Lasa Supergenerics Ltd faced significant trading activity today, hitting its lower circuit limit with a notable decline. The stock's performance was below the sector average, and investor participation decreased sharply. Despite remaining above several moving averages, it traded below its 200-day moving average, indicating a shift in market sentiment."
      }
    ],
    "total": 202,
    "sid": "1002834",
    "stock_news_url": "https://www.marketsmojo.com/news/lasa-supergenerics-1002834"
  },
  "announcements": [
    {
      "details": "Lasa Supergenerics Limited has informed the Exchange regarding 'we have been granted patents for our key products the period of 20 years from the date of Filing'.",
      "source": "NSE",
      "caption": "Lasa Supergenerics Limited - Updates",
      "datetime": "05-Dec-2019"
    },
    {
      "details": "Lasa Supergenerics Limited has informed the Exchange regarding Corrigendum to detailed public statement published on September 06, 2019 for the attention of equity shareholders of company.",
      "source": "NSE",
      "caption": "Lasa Supergenerics Limited - Corrigendum",
      "datetime": "27-Nov-2019"
    },
    {
      "details": "Lasa Supergenerics Limited has informed the Exchange regarding 'Letter of Offer'.",
      "source": "NSE",
      "caption": "Lasa Supergenerics Limited - Updates",
      "datetime": "26-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lasa Supergenerics Ltd has declared <strong>2%</strong> dividend, ex-date: 16 Sep 22",
          "dt": "2022-09-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Why is Lasa Supergeneri falling/rising?

2025-12-13 01:17:14

Recent Price Movement and Market Context

Despite the recent positive price action, Lasa Supergenerics has endured a challenging period over the past year and beyond. The stock has declined by 64.01% over the last 12 months and by a staggering 87.85% over five years, significantly underperforming the broader Sensex benchmark, which has gained 4.89% and 84.97% respectively over the same periods. Year-to-date, the stock remains down 62.11%, contrasting sharply with the Sensex’s 9.12% gain. This prolonged underperformance highlights the stock’s vulnerability and the cautious stance investors have maintained.

However, the recent price increase on 12-Dec marks a departure from this trend. The stock outperformed its sector by 5.67% on the day, suggesting renewed buying intere...

Lasa Supergeneri Sees Revision in Market Evaluation Amid Challenging Financials

2025-12-07 10:10:21

Lasa Supergeneri, a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable revision in its market evaluation metrics. This shift reflects recent developments across multiple analytical parameters, highlighting ongoing challenges in the company’s financial and operational performance.

Lasa Supergenerics Hits Lower Circuit Amid Heavy Selling Pressure

2025-11-24 15:00:09

Lasa Supergenerics Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 24 Nov 2025 as it hit its lower circuit limit, reflecting intense selling pressure and a significant daily loss that outpaced both its sector and the broader market indices.

Lasa Supergenerics Faces Intense Selling Pressure Amid Prolonged Downtrend

2025-11-24 14:21:03

Lasa Supergenerics Ltd has encountered significant selling pressure, with the stock registering a sharp decline of 4.91% today and exhibiting a complete absence of buyers. This extreme selling activity reflects distress signals as the pharmaceutical company continues to underperform against broader market indices and its sector peers.

Why is Lasa Supergeneri falling/rising?

2025-11-19 23:35:31

As of 19-Nov, Lasa Supergenerics Ltd is currently priced at 10.27, reflecting a slight increase of 0.02 (0.2%). The stock has experienced a trend reversal, gaining after four consecutive days of decline. However, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally bearish trend. Additionally, there has been a significant drop in investor participation, with delivery volume on 18 Nov falling by 91.48% compared to the 5-day average. The stock has underperformed in the longer term, with a year-to-date decline of 60.26% and a 5-year decline of 86.66%, which suggests ongoing challenges despite today's minor uptick. In the broader market context, Lasa Supergenerics' short-term performance has been notably poor compared to the benchmark Sensex, which has gained 0.85% over the past week while Lasa has declined by 6.47%. This stark contrast highlights the stoc...

Lasa Supergenerics Ltd Stock Hits Upper Circuit Limit with Intraday High of Rs 10.76

2025-11-17 11:00:18

Lasa Supergenerics Ltd, a microcap in the Pharmaceuticals & Biotechnology sector, reached its upper circuit limit today, with a notable increase in investor participation. The stock's trading volume surged significantly, reflecting strong market activity despite being below its moving averages across various time frames.

How has been the historical performance of Lasa Supergeneri?

2025-11-15 00:12:35

Answer: The historical performance of Lasa Supergeneri shows significant fluctuations in key financial metrics over the years. Breakdown: Lasa Supergeneri's net sales have varied, peaking at 202.38 Cr in March 2021 but declining to 142.45 Cr by March 2025, with a notable drop from 137.13 Cr in March 2022. Total operating income followed a similar trend, reflecting the same values as net sales. Raw material costs increased to 108.10 Cr in March 2025 from 79.28 Cr in March 2024, while total expenditure rose to 136.18 Cr in March 2025, indicating rising operational costs. Operating profit, which was positive at 47.22 Cr in March 2021, turned negative in March 2023 at -6.59 Cr and improved to 6.27 Cr by March 2025. Profit before tax remained negative, reaching -19.38 Cr in March 2025, with profit after tax also negative at -14.76 Cr. The company's equity capital remained stable at 50.10 Cr from March 2023 to M...

Why is Lasa Supergeneri falling/rising?

2025-11-11 23:23:57

As of 11-Nov, Lasa Supergenerics Ltd is experiencing a decline in its stock price, currently at 10.76, which reflects a decrease of 0.56 or 4.95%. The stock has been underperforming significantly, with a consecutive fall over the last five days resulting in an overall drop of 8.03%. It is trading below all key moving averages, indicating a bearish trend. Additionally, investor participation has decreased sharply, with delivery volume falling by 80.49% compared to the five-day average. The stock has also shown poor performance over various periods, with year-to-date returns down by 58.36% and a staggering 86.07% decline over the past five years. In the broader market context, Lasa Supergenerics Ltd's recent performance contrasts sharply with the Sensex, which has gained 7.34% year-to-date. Over the past week, while the Sensex has increased by 0.49%, Lasa Supergenerics has declined by 7.88%, highlighting its...

Lasa Supergenerics Ltd Hits Lower Circuit Limit with Low Price of Rs 11.02

2025-11-03 11:00:18

Lasa Supergenerics Ltd faced significant trading activity today, hitting its lower circuit limit with a notable decline. The stock's performance was below the sector average, and investor participation decreased sharply. Despite remaining above several moving averages, it traded below its 200-day moving average, indicating a shift in market sentiment.

View All News

Announcement

Lasa Supergenerics Limited - Updates

05-Dec-2019 | Source : NSE

Lasa Supergenerics Limited has informed the Exchange regarding 'we have been granted patents for our key products the period of 20 years from the date of Filing'.

Lasa Supergenerics Limited - Corrigendum

27-Nov-2019 | Source : NSE

Lasa Supergenerics Limited has informed the Exchange regarding Corrigendum to detailed public statement published on September 06, 2019 for the attention of equity shareholders of company.